statements

Arvee Laboratories (India) Ltd.

NSE: ARVEE

Sector: Chemicals

Industry Group: Chemicals & Petrochemicals

Industry: Specialty Chemicals

181.80-0.2 (-0.14%)

26 Aug, 9:29 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Arvee Laboratories (India) Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	3.44	11.80	12.97	26.82	34.42	47.78	54.90	45.42	47.38	40.33	61.35	30.35	38.49	31.51	41.26
Cost of Operating Revenue	2.86	7.56	8.22	18.12	24.79	32.05	41.57	31.45	31.90	24.75	45.00	18.76	24.61	15.88	23.73
Gross Profit	0.58	4.24	4.75	8.70	9.63	15.73	13.33	13.96	15.48	15.57	16.35	11.58	13.88	15.64	17.53
Gross Margin	16.9	35.9	36.6	32.4	28.0	32.9	24.3	30.7	32.7	38.6	26.6	38.2	36.1	49.6	42.5
Total Operating Expenses	3.27	10.21	11.60	23.32	30.60	42.76	51.08	41.69	43.72	36.98	56.15	28.85	36.02	29.53	37.15
Operating Profit	0.17	1.59	1.36	3.51	3.82	5.02	3.82	3.73	3.65	3.34	5.20	1.50	2.46	1.98	4.11
Operating Margin	4.9	13.4	10.5	13.1	11.1	10.5	7.0	8.2	7.7	8.3	8.5	4.9	6.4	6.3	10.0
Financing Income/(Expense) - Net	-0.23	-1.60	-2.45	-3.07	-3.48	-3.33	-1.63	-0.99	-0.58	-0.36	0.96	0.32	0.40	-0.23	-0.26
Profit before Taxes	0.05	0.02	-1.01	0.54	0.86	1.92	2.54	3.09	3.64	3.45	6.17	1.83	2.87	2.43	4.54
Income Taxes	0.01	0.00	0.64	0.35	-0.69	0.83	0.28	0.86	0.96	0.88	2.05	0.78	0.72	-0.10	0.49
Profit after Tax	0.04	0.02	-1.65	0.19	1.55	1.09	2.26	2.23	2.68	2.57	4.12	1.05	2.15	2.53	4.05
PAT Margin	1.2	0.2	-12.7	0.7	4.5	2.3	4.1	4.9	5.7	6.4	6.7	3.5	5.6	8.0	9.8
EPS - Basic - ex Extraordinary Items	0.04	0.02	-1.49	0.17	1.41	1.29	2.05	2.02	2.43	2.29	3.74	0.95	1.95	2.29	3.68
EPS - Diluted - ex Extraordinary Items	0.04	0.02	-1.49	0.17	1.41	1.29	2.05	2.02	2.43	2.29	3.74	0.95	1.95	2.29	3.68
EBIT	0.17	1.59	1.36	3.51	3.82	5.02	3.82	3.73	3.65	3.34	5.20	1.50	2.46	1.98	4.11
EBITDA	0.18	1.81	2.09	4.99	5.89	7.17	6.17	6.02	6.06	5.67	7.28	3.00	3.61	3.20	5.35
EBITDA Margin	5.1	15.3	16.1	18.6	17.1	15.0	11.2	13.3	12.8	14.0	11.9	9.9	9.4	10.1	13.0

Balance Sheet

Abridged

Understanding Balance Sheet

Arvee Laboratories (India) Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	PR	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	5.54	7.90	11.56	17.66	18.65	27.31	21.42	18.09	25.55	22.16	21.57	16.98	19.66	25.23
Long-Term Investments	-	-	-	-	-	-	-	-	0.24	1.70	2.35	5.67	1.07	0.25
Property Plant & Equipment - Net	3.34	9.38	14.33	17.46	16.88	16.06	14.92	14.93	14.75	14.80	14.20	15.29	16.00	17.61
Total Non-Current Assets	3.36	9.52	14.47	17.54	17.02	16.80	15.73	15.54	15.49	16.52	17.12	21.58	17.91	18.03
Total Assets	8.91	17.42	26.03	35.21	35.67	44.12	37.15	33.62	41.05	38.68	38.69	38.56	37.57	43.26
Total Current Liabilities	1.51	6.38	8.71	14.20	14.78	21.31	16.65	12.56	18.29	13.29	8.84	7.13	3.83	7.54
Long Term Debt	7.31	7.98	15.26	17.38	16.57	7.88	3.47	1.96	1.00	1.00	1.00	1.00	1.03	1.11
Total Non-Current Liabilities	7.31	7.98	15.90	18.37	16.70	8.61	4.03	2.38	1.31	1.45	1.78	2.32	2.49	1.93
Total Liabilities	8.81	14.36	24.61	32.57	31.48	29.92	20.69	14.94	19.61	14.74	10.62	9.45	6.31	9.47
Total Shareholders' Equity	0.09	3.06	1.41	2.64	4.19	14.20	16.46	18.69	21.44	23.94	28.06	29.11	31.26	33.79
Total Equity	0.09	3.06	1.41	2.64	4.19	14.20	16.46	18.69	21.44	23.94	28.06	29.11	31.26	33.79
Total Liabilities & Equity	8.91	17.42	26.03	35.21	35.67	44.12	37.15	33.62	41.05	38.68	38.69	38.56	37.57	43.26

Cash Flow

Abridged

Understanding Cash Flow Statement

Arvee Laboratories (India) Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	0.05	0.24	-0.28	2.02	3.63	3.48	4.61	4.31	4.87	4.76	6.49	2.83	3.30	3.29
Working Capital - Increase/(Decrease)	3.67	-2.15	6.50	1.23	-2.56	-0.69	3.76	5.27	-3.37	-4.13	-3.64	1.00	-3.26	-3.36
Net CF from Operating Activities	3.72	-1.91	6.22	3.25	1.06	2.80	8.37	9.58	1.50	0.63	2.84	3.83	0.05	-0.07
Capital Expenditures - Net	3.34	6.28	5.67	4.62	1.49	1.34	1.50	2.29	2.24	2.36	1.47	2.59	1.85	2.83
Net CF from Investing Activities	-3.34	-6.28	-5.67	-4.62	-1.49	-1.34	-3.20	-3.22	-0.89	-0.21	-1.46	-2.52	-1.72	0.22
Stock - Issuance/(Retirement) - Net	-	2.95	-	1.05	-	1.46	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-0.37	5.30	0.18	0.76	0.14	-9.12	-3.49	-9.03	5.01	-5.75	-2.13	-	0.03	0.08
Net Cash Flow from Financing Activities	-0.37	8.25	0.18	1.81	0.14	-0.45	-3.49	-9.03	5.01	-5.75	-2.13	-	0.03	0.08
Free Cash Flow to Equity	0.01	-2.89	0.73	-0.60	-0.29	-7.66	3.38	-1.73	4.27	-7.48	-0.75	1.25	-1.77	-2.82
Free Operating CF net dividend	0.38	-8.19	0.55	-1.36	-0.46	1.46	6.87	7.30	-0.79	-1.73	1.36	1.25	-1.81	-2.90
Free Operating CF	0.38	-8.19	0.55	-1.36	-0.46	1.46	6.87	7.30	-0.79	-1.73	1.36	1.25	-1.81	-2.90

Business Segment Analysis

FY End:

Mar 25

Arvee Laboratories (India) Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Chemicals (100.0%)₹ 1.85 Cr

Revenue / Sales

Chemicals (100.0%)₹ 38.49 Cr

Assets

Chemicals (100.0%)₹ 37.57 Cr

Operating Income

Chemicals (100.0%)₹ 2.46 Cr

Regional Segment Analysis

Arvee Laboratories (India) Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Arvee Laboratories (India) Ltd.

Historical Segment Analysis

Track how Arvee Laboratories (India) Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2023 Mar 31	2024 Mar 31	2025 Mar 31
	2023 Mar 31	2024 Mar 31	2025 Mar 31
Chemicals	1	3	2

Frequently Asked Questions

What is the revenue of Arvee Laboratories (India) Ltd.?

The latest trailing twelve month revenue of Arvee Laboratories (India) Ltd. is ₹ 41.26 Cr, reflecting a 1-year growth of 16.67% and a 3-year CAGR of -6.68%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Arvee Laboratories (India) Ltd.?

The latest trailing twelve month net profit (PAT) of Arvee Laboratories (India) Ltd. is ₹ 4.05 Cr, with a 3-year earnings CAGR of -15.08%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Arvee Laboratories (India) Ltd.?

The trailing twelve month EBITDA of Arvee Laboratories (India) Ltd. is approximately ₹ 4.11 Cr (based on an operating margin of 9.96%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Arvee Laboratories (India) Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Arvee Laboratories (India) Ltd. is 2.29. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Arvee Laboratories (India) Ltd.?

The debt-to-equity ratio of Arvee Laboratories (India) Ltd. stands at 0.03. The interest coverage ratio is 16.02x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Arvee Laboratories (India) Ltd.?

The estimated book value per share of Arvee Laboratories (India) Ltd. is 30.62 (derived from a P/B ratio of 5.94 and market price of ₹ 181.80), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Arvee Laboratories (India) Ltd.?

The trailing twelve month operating cash flow of Arvee Laboratories (India) Ltd. is ₹ -0.07 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Arvee Laboratories (India) Ltd. report consolidated or standalone financials?

Arvee Laboratories (India) Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.